Store operated calcium entry (SOCE) is a principal cellular process by which cells regulate basal calcium, refill intracellular Ca 2+ stores, and execute a wide range of specialized activities. STIM and Orai proteins have been identified as the essential components enabling the reconstitution of Ca 2+ release-activated Ca 2+ (CRAC) channels that mediate SOCE. Here, we report the molecular identification of SARAF as a negative regulator of SOCE. Using heterologous expression, RNAi-mediated silencing and site directed mutagenesis combined with electrophysiological, biochemical and imaging techniques we show that SARAF is an endoplasmic reticulum membrane resident protein that associates with STIM to facilitate slow Ca 2+
SUMMARY
Store operated calcium entry (SOCE) is a principal cellular process by which cells regulate basal calcium, refill intracellular Ca 2+ stores, and execute a wide range of specialized activities. STIM and Orai proteins have been identified as the essential components enabling the reconstitution of Ca 2+ release-activated Ca 2+ (CRAC) channels that mediate SOCE. Here, we report the molecular identification of SARAF as a negative regulator of SOCE. Using heterologous expression, RNAi-mediated silencing and site directed mutagenesis combined with electrophysiological, biochemical and imaging techniques we show that SARAF is an endoplasmic reticulum membrane resident protein that associates with STIM to facilitate slow Ca 2+ -dependent inactivation of SOCE. SARAF plays a key role in shaping cytosolic Ca 2+ signals and determining the content of the major intracellular Ca 2+ stores, a role that is likely to be important in protecting cells from Ca homeostasis (Parekh and Putney, 2005) . Despite its initial characterization more than two decades ago, when SOCE was characterized mainly via mechanistic and biophysical means, only recently have the molecular components essential for its activity been identified. The molecular identification revealed the discrete events associated with SOCE activation and regulation (Cahalan, 2009; Lewis, 2007; Putney, 1986) . STIM and Orai proteins are the essential components that enable the reconstitution of Ca 2+ release-activated Ca 2+ (CRAC) channels underlying SOCE activity Liou et al., 2005; Peinelt et al., 2006; Prakriya et al., 2006; Roos et al., 2005; Soboloff et al., 2006; Vig et al., 2006; Zhang et al., 2006; Zhang et al., 2005) . Although other proteins, such as members of the TRPC family, might also be involved in SOCE (Hardie and Minke, 1993; Kiselyov et al., 1998; Liu et al., 2007; Pani et al., 2009) , STIM, the Ca 2+ sensor (Liou et al., 2005; Roos et al., 2005; Stathopulos et al., 2008; Zhang et al., 2005) , and Orai, the channel pore forming subunit Vig et al., 2006; Yeromin et al., 2006) , have been shown to be sufficient for this activity. STIM is an endoplasmic reticulum (ER) single pass membrane protein , which detects changes in ER Ca 2+ levels through a conserved Ca 2+ binding domain (EF hand) (Stathopulos et al., 2009; Stathopulos et al., 2008) . ER Ca 2+ depletion leads to STIM oligomerization and relocalization to specialized regions close to the plasma membrane (ER-PM junctions), where it directly binds to Orai, causing the opening of the channel and initiation of Ca 2+ entry (Baba et al., 2006; Barr et al., 2008; Frischauf et al., 2009; Kawasaki et al., 2009; Liou et al., 2007; Liou et al., 2005; Muik et al., 2008; Navarro-Borelly et al., 2008; Park et al., 2009; Wu et al., 2006; Yuan et al., 2009; Zhang et al., 2005; Zhou et al., 2010) . Once SOCE is activated, it is subjected to various direct and indirect regulatory processes that determine the duration and magnitude of the Ca 2+ influx, which set downstream cellular events Parekh and Putney, 2005) . Two definitive Ca
2+
-dependent modes of regulation of CRAC channels were previously reported: fast inactivation that depends largely on STIM1 and calmodulin binding to Orai1 Hoth and Penner, 1993; Lee et al., 2009; Litjens et al., 2004; Mullins et al., 2009 ) and a slow Ca 2+ -dependent inactivation process with an unknown molecular mechanism (Louzao et al., 1996; Parekh, 1998; Zweifach and Lewis, 1995) . Using a functional-based high-throughput screen, we have identified the gene product of TMEM66, named hereafter as SARAF (for SOCE-associated regulatory factor) as a regulator of cellular Ca 2+ homeostasis. SARAF is a highly conserved protein in vertebrates and has poor functional annotation. In mammals, SARAF is ubiquitously expressed but has exceptionally high transcript levels in the immune and neuronal tissues (Su et al., 2004) . In this study we show that SARAF is an ER resident protein, which responds to cytosolic Ca 2+ elevation after ER Ca 2+ refilling by promoting a slow inactivation process of STIM2-dependent basal SOCE activity, as well as STIM1-mediated SOCE activity. These actions collectively impose stringent conditions for maintaining proper intracellular Ca 2+ levels in both resting and stimulated cells.
RESULTS

SARAF Regulates Basal ER and Cytosolic Ca 2+ Levels
We performed a functional expression screen in an attempt to isolate cDNA candidates that affect mitochondrial Ca 2+ homeostasis (Figures S1A and S1B, available online). These efforts lead to the identification of a $2 kilobase cDNA clone with a 1020 bp open reading frame coding for SARAF (accession #JQ348891) (also known as TMEM66, XTP-3, FOAP-7, HSPC035, MGC8721 or FLJ22274) ( Figure 1A ] cyto in both cell types ( Figures 1D-1F ). Likewise, [Ca 2+ ] ER levels, estimated by organelle content release using ionomycin (Brandman et al., 2007) or with the D1ER indicator, were higher in siRNA-treated cells, ( Figure 1F inset and Figure S1D ). The specificity and efficiency of siRNA-mediated silencing of SARAF mRNA and protein levels were determined by western blotting, semiquantitative RT-PCR, and a fluorescent-based assay employing YFP fluorescence as reference for protein expression ( Figure 1D and Figure S2 ). The functionality of SARAF-YFP suggested that the protein is correctly expressed and folded and therefore encouraged us to study its cellular localization. When a fluorescent-tagged chimera of SARAF was coexpressed with either that of STIM1 or SEC61, both ER resident proteins, SARAF fluorescence strongly overlapped with both markers ( Figure 1G and Figure S1E ), but did not colocalize with that of mitochondrial markers (data not shown), indicating that the ER is the primary site for SARAF subcellular localization.
At resting conditions, SARAF modulation of [Ca 2+ ] i must involve a change of Ca 2+ fluxes at the level of the plasma membrane (Ríos, 2010) . This can be achieved either through the regulation of plasma membrane Ca 2+ permeation or extrusion pathways. In order to distinguish between these two possibilities, we overexpressed SARAF in HEK293-T and translates them into differential gating of Orai1 (Brandman et al., 2007) . To test whether SARAF regulation of basal [Ca 2+ ] cyto is linked to the STIM2-Orai1 pathway, we used siRNA-mediated knock down of STIM2, either alone, or together with SARAF, and determined basal [Ca 2+ ] cyto in HeLa cells. In agreement with previous studies (Bird et al., 2009; Brandman et al., 2007) , we observed a significant decrease in [Ca 2+ ] cyto after STIM2
silencing, compared to control ( Figure 1H ). (Zweifach and Lewis, 1995 (Figures S2A and S2B) . These had similar magnitudes in both control-expressing (HEK293 22.6 ± 2 pA/pF and HEK239-T 40.7 ± 3.5 pA/pF) and SARAF-expressing (HEK293 27.1 ± 6pA/pF and HEK293-T 41.8 ± 3.3 pA/pF) cells. Strikingly, we found clear differences in current inactivation. In control HEK293 cells, currents partially inactivated to steady-state levels (35.6% ± 3.2% of peak levels), whereas in SARAF-expressing cells, the extent of current inactivation was greatly increased (17.3% ± 1% of peak levels, Figure 2A ). An additional period of passive store depletion, when no external Ca 2+ was present, partially restored I CRAC in control cells (46.5% ± 4.7% of peak levels), whereas in SARAF-expressing cells, currents remained inactivated (21% ± 3% of peak levels). These results indicate that part of the SARAF-mediated I CRAC inhibition does not require the continuous presence of elevated Ca
2+
. Similar results were also obtained from HEK293-T cells under the same experimental conditions ( Figures S3A and S3B ). Intriguingly, a similar ''slow inactivation'' process of native I CRAC currents in Jurkat T-lymphocytes and RBL cells has been observed (Parekh, 1998; Zweifach and Lewis, 1995) ; however, the molecular component responsible for this process remained unknown. The continuous nature of the SARAF-mediated I CRAC inhibition suggests that inhibition may be Ca 2+ dependent. We therefore performed similar experiments as described above using the faster Ca 2+ chelator, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid (BAPTA) (10 mM), in the pipette solution. Under these experimental conditions, I CRAC currents were of similar magnitude for both control and SARAF-expressing cells and did not undergo inactivation ( Figure 2B ). These results suggest that the onset of SARAF-mediated I CRAC inactivation depends on the presence of free cytosolic Ca 2+ ions. To address more specifically whether ER luminal Ca 2+ content affects SARAFmediated I CRAC inhibition, we repeated the experimental paradigm as in Figure 2A with the addition of 2 mM Thapsigargin (Tg), an irreversible SERCA (sarcoplasmic/endoplasmic reticulum Ca
-ATPase), in the patch pipette solution. In the absence of ER Ca 2+ refilling, both control and SARAF-expressing cells exhibited reduced I CRAC inactivation ( Figure 2C ) compared to conditions that allow ER Ca 2+ refilling (Figure 2A ), indicating that store refilling partially contributes to the inactivation process. In the absence or presence of Tg, the extent of current inactivation in control cells was 35.6% ± 3.2% (from Figure 2A ) and 80.6% ± 4.4% of peak levels, respectively. Similar changes were seen in cells expressing SARAF, with 17.3% ± 1% (from Figure 2A ) and 40% ± 1.6% of peak levels, respectively. These data suggest that there is a substantial component of I CRAC inactivation that is dependent on luminal Ca
, which in turn may be partially modulated by SARAF. In order to further confirm that SARAF is indeed involved in regulating Ca 2+ entry upon ER -free extracellular solution (1 mM EGTA) (Brandman et al., 2007) for 45 min prior to the initiation of experiment. Transient ER Ca 2+ depletion was induced by bath application of 100 mM ATP and 100 mM carbachol (Carb) ( Figure 2D ). In cells coexpressing Orai1, STIM1, and SARAF, the rise in [Ca 2+ ] cyto after the addition of extracellular Ca 2+ was about 2-fold lower than in STIM1-and Orai1-coexpressing cells ( Figure 2D ). In contrast, under conditions where SOCE activity was induced by Tg, the apparent ability of SARAF to inhibit SOCE activity was greatly diminished. It should be noted that a small but persistent difference in [Ca 2+ ] cyto rise under these conditions was maintained between SARAF-expressing and control cells (an average of 13.9% ± 2.2% in the relative R max value, from seven independent experiments, p < 0.05, t test analysis). The apparent nonlinear correlation between the effects of SARAF on steady- Figure 2E ). To substantiate that indeed SARAF is playing an important role in regulating SOCE activity under native conditions, we measured SOCE activity in Jurkat T cells where endogenous SARAF levels were reduced by siRNA. In these cells, we performed both transient activation of SOCE (using anti-CD3) and permanent activation (using Tg) by using a similar experimental paradigm to that described in Figure 2D ( Figure 2F and Figure S3E ). SOCE activation by CD3-induced store depletion in siSARAF-treated Jurkat cells resulted in prolonged elevation of [Ca 2+ ] cyto , whereas control cells exhibited similar initial Ca 2+ elevation, which later decreased to levels that were about 2-fold lower than in SARAF-silenced cells. SOCE induction by Tg showed no significant differences between control and siSARAF-treated cells, which is similar to the experiments with HEK293 cells ( Figure S3E ). Similar results were also obtained from HeLa cells in which SARAF expression was either elevated via SARAF cDNA expression or reduced by siSARAF ( Figures S3C and S3D) , thus emphasizing the ubiquitous nature of SARAF action. To confirm that endogenous SARAF was indeed the molecular component responsible for SOCE inactivation, we tested the ability of the murine form of SARAF (mSARAF), whose mRNA is not targeted by the human siSARAF used in the above experiments ( Figure S2F ), to rescue the SARAF phenotype. Jurkat cells were cotransfected with si-SARAF with or without mSARAF cDNA, and SOCE was activated by the reversible SERCA inhibitor BHQ (2,5-Di-t-butyl-1,4-benzohydroquinone). mSARAF rescued SOCE inactivation, indicating that SARAF is the molecular component responsible for SOCE inactivation ( Figure 2G and Figures S3F-S3H) . Similarly, recording of I CRAC from Jurkat cells treated with siSARAF also showed a reduction in current inactivation; in control cells, currents remaining after 4 min in the presence of high external Ca 2+ were 15.2% ± 5% (n = 15), whereas in siSARAF-treated cells, currents were 82% ± 4% (n = 9, p < 0.05) ( Figure 2H ). Current densities in control and siSARAF-treated Jurkat cells, however, were similar, with values of 1.35 ± 0.10 pA/pF and 1.17 ± 0.06 pA/pF, respectively. As an independent third measure for the possible action of SARAF on SOCE activity, we assessed the ability of SARAF to interfere with the Ca 2+ -dependent translocation of the nuclear factor of activated T cells (NFAT-GFP) to the cell nucleus (Tomida et al., 2003) . In unstimulated cells, coexpressing STIM1 and Orai1 with or without SARAF, NFAT-GFP was predominantly found in the cytoplasm. After ER Ca 2+ depletion by BHQ and the reintroduction of external Ca
, in cells expressing STIM1 and Orai1, 73% ± 2.8% of the cells exhibited nuclear NFAT-GFP localization, compared to only 44% ± 3.1% of the cells expressing STIM1, ORAI1, and SARAF. In contrast, when ER refilling was abolished by Tg, nearly all cells exhibited nuclear localization of NFAT and the expression of SARAF no longer made a significant difference (Figures 2I and  2J) . The experiments described above indicate that SARAF-mediated SOCE inactivation primarily depends on cytosolic Ca 2+ rise and is partially affected by the ER Ca 2+ refilling state.
SARAF Translocates to ER-PM Regions in a STIM1-Dependent Manner after Store Depletion
One of the most prominent manifestations of STIM1-Orai1-induced SOCE is the puncta formation of a multimeric STIM1-Orai1 protein aggregate at specialized ER-PM junctions (Liou et al., 2005) . If SARAF directly inhibits SOCE, it should be found at these active sites as well. Indeed, in cells coexpressing SARAF-GFP together with STIM1-mCherry and Orai1, but not in cells expressing SARAF-GFP alone, upon depletion of ER stores with Tg, a significant translocation of SARAF-GFP and STIM1-mCherry to the plasma membrane was apparent (Figure 3A-3C and Movie S1). SARAF-GFP translocation into ER-PM regions did not depend on the [Ca 2+ ] cyto because chelation of free cytosolic Ca 2+ did not prevent it ( Figure S4D ). These results indicate that ER depletion alone is not sufficient for SARAF translocation and that either Orai1 or STIM1 were essential for this process. To test whether endogenous STIM played a role in the Tg-induced SARAF translocation, we coexpressed SARAF-GFP and Orai1-mCherry in siSTIM1 and siSTIM2-treated cells ( Figures S4A-S4C ) and monitored their cellular localization. Silencing STIM1 and STIM2 protein levels inhibited the Tg-induced SARAF-GFP translocation in the presence of Orai1-mCherry ( Figure 3D ). These results indicate that after store depletion, SARAF ability to translocate into ER-PM regions depends primarily on the presence of STIM proteins. ( Zhang and Henzel, 2004 ) and a single putative transmembrane domain (aa 173-195) . SARAF topology predicts a cytoplasm facing domain (aa 196-339) and an ER-luminal facing domain (aa 31-172) ( Figure 1A ). We cloned an additional splice isoform of the human SARAF gene, SARAF-S, from HEK293 cells (accession number JQ348892). This splice isoform lacks the second exon of the full-length SARAF and results in a shorter open reading frame (ORF), corresponding to aa 173-339 (the ORF is identical to AK315956). The short isoform exhibits similar cellular distribution and translocates to ER-PM regions after SOCE activation, similar to the full-length protein ( Figure S5A ). To elucidate the potential differential roles played by either the luminal or the cytosolic domains of SARAF, we created YFP fusions with either N-terminal (aa 1-191) or C-terminal (aa 196-339) domains and tested their ability to regulate SOCE. We repeated the same experimental paradigm as in Figure 2D and measured SOCE under both store refilling and nonrefilling conditions. Remarkably, truncation of SARAF C-terminal cytosolic domain eliminated SOCE modulation. In contrast, truncation of SARAF luminal N-terminal domain resulted in strong inhibition of SOCE that exhibited little dependence on store refilling ( Figure 4A ). To further address this issue we measured I CRAC currents in the absence of store refilling in cells expressing C 0 -SARAF using the same experimental conditions as in Figure 2C . Strikingly, in the absence of store refilling, in cells expressing C 0 -SARAF isoform currents inactivated to 20.8% ± 2.8% of peak levels, whereas in control cells the extent of current inactivation was more than 3-fold lower (64.6% ± 5.2%, Figure 4B ). Peak current densities were similar in both control-expressing (31 ± 1.4 pA/ pF, n = 14) and C 0 -SARAF-expressing (29 ± 2.3 pA/pF, n = 8) cells, indicating that SOCE inactivation by the C 0 -SARAF remained dependent on cytosolic Ca 2+ . To test whether the C 0 -SARAF interacts directly with STIM1 or Orai1, we performed immuno-pull down analysis by using purified YFP-C 0 -SARAF (aa 196-339) and extracts from HEK293-T cells coexpressing STIM1 and Orai1-HA. We found that YFP-C 0 -SARAF mainly precipitated STIM1; traces of Orai1 immunopercipitate were also detected, which may be attributed to its native interaction with STIM1 ( Figure 4C ). In contrast, similar immuno-pull down analysis using N 0 -SARAF-YFP were inconclusive and indicated a very weak, if any, interaction with STIM1 ( Figure S5F ). From the above functional assays, it was expected that C 0 -SARAF would colocalize at ER-PM junctions upon store depletion in a STIM1-dependnet manner. Indeed, cells expressing both YFP-C 0 -SARAF and mCherry-Orai1 exhibited dispersed cytosolic staining that did not overlap with that of mCherry-Orai1 ( Figure 4D ). In contrast, when STIM1 was also coexpressed, YFP-C 0 -SARAF could be found in reticular structures that moved close to plasma membrane regions upon store depletion to form the classical puncta as described in Figure 3B (see also Figure 4D) . The reticular like structures of YFP-C 0 -SARAF colocalized with STIM1-mCherry, and formation of these structures did not require Orai1 (Figures S5C-S5E ). Taken together, the above results suggests that the SARAF C-terminal domain recognizes a domain on STIM1 that enables it to control SOCE activity, whereas the luminal N-terminal domain is responsible for the regulation of SARAF inhibitory activity. To further test this hypothesis, we mutated a conserved glutamate (E148) in the N-terminal region of SARAF and tested its effect on SARAF activity. SARAF(E148A) dominantly inactivated SARAF phenotypic activity both on SOCE and on NFAT translocation ( Figures  4E-4G ), similar to the phenotype seen after its silencing with siRNA. Moreover, the SARAF(E148A)-YFP mutant exhibited normal translocation into Orai1 puncta at ER-plasma membrane junctions upon store depletion ( Figure S5B ).
SARAF Luminal Domain Regulates Its
SARAF Associates with STIM1 at Rest
To further test the mode of interaction between SARAF and STIM1, we coexpressed SARAF-GFP and STIM1-mCherry and used a FRET (Fö rster resonance energy transfer)-based approach to test for intermolecular interactions between the two proteins. Remarkably, resting cells without SOCE stimulation, exhibited a significant FRET signal between SARAF-GFP and STIM1-mCherry. The specificity of this signal was validated in several ways. First, to check for random collisions that may occur between the two constructs, we replaced the donor SARAF-GFP with a cytosolic expressed GFP. Under these conditions, no FRET could be detected between GFP and STIM1-mCherry ( Figures 5A and 5B) . Next, to test whether true donor and acceptor interactions were responsible for the FRET signal within the oligomer, we coexpressed SARAF-GFP with STIM1-mCherry and added untagged SARAF to compete with SARAF-GFP on STIM1-mCherry binding. Adding untagged SARAF resulted in a decrease in the FRET signal between SARAF-GFP and STIM1-mCherry ( Figure 5C ). Likewise, the reverse competition with untagged STIM1, underlining the specific interaction between the two molecules. Finally, acceptor photobleaching was used to verify that indeed, destruction of the acceptor dequench donor fluorescence ( Figures S6A and S6B ) (Riven et al., 2003) . Furthermore, independent measurements of FRET were also obtained using the time-domain approach, by measuring fluorescent donor life-time changes, fluorescence lifetime imaging microscopy (FLIM) (Raveh et al., 2010) (Figures  S6C-S6F ). These measurements verified our initial observation and confirmed that STIM1 and SARAF interact at rest. We then measured FRET changes during SOCE activation after the application of a combination of ATP, Carb, and Tg to cells that express SARAF-GFP and STIM1-mCherry in the presence or absence of Orai1. Remarkably, about a 20% FRET change in the mCherry/GFP ratio was observed only in cells that contained both STIM1 and Orai1 ( Figure 5D ). The increase in FRET between STIM1 and SARAF after store depletion was reversible when the stores were allowed to refill ( Figures S6E and S6F ). These results indicate that SARAF and STIM1 associate under resting conditions and that SOCE activation promotes molecular rearrangements between STIM1 and SARAF C termini in an Orai1-dependent manner.
SARAF Inhibits Spontaneous Activation of STIM1
In order to study the functional consequences of STIM1 and SARAF interaction under resting conditions, we silenced endogenous SARAF expression and analyzed STIM1 and Orai1 activity and distribution. In control cells under resting conditions, we observed a reticular staining pattern for YFP-STIM1 that was also evident, in part, near plasma membrane regions with a uniform Orai1-mCherry plasma membrane staining. After ER depletion, this morphology changed into intense colocalized punctate fluorescence signals from both YFP-STIM1 and Orai1-mCherry at plasma membrane regions ( Figure 6A ). When cells where endogenous SARAF expression was reduced were at rest, YFP-STIM1 fluorescence near the plasma membrane was significantly increased with both STIM1-YFP and Orai1-mCherry forming fluorescent puncta ( Figure 6A ). After the depletion of Ca 2+ from the ER by Tg, a smaller additional recruitment of YFP-STIM1 into puncta was apparent but with an overall effect that was similar to control cells under similar conditions. To test the functional consequences of this effect on SOCE, we measured NFAT translocation and [Ca 2+ ] cyto levels under similar conditions. Basal [Ca 2+ ] cyto was significantly elevated in siSARAF-treated cells, a difference that could be reversed by either rescuing SARAF expression by mSARAF or by omitting external Ca 2+ from the incubation medium ( Figure 6C ). In agreement with the increased basal SOCE, enhanced nuclear localization of NFAT was also observed in siSARAF-treated cells under either basal conditions or after reversal depletion of the stores ( Figure 6D ).
SARAF Enhances STIM1 Deoligomerization upon Store Refilling
To gain further insight into the mechanism by which SARAF modulates SOCE, we raised the question whether STIM1-STIM1 oligomeric interactions that underlie SOCE activation and inactivation, are affected by the presence of SARAF. For this purpose, we expressed STIM1-GFP, STIM1-mCherry, and Orai1 with or without SARAF and monitored the dynamics of FRET signals between STIM1-GFP/mCherry during ER Ca 2+ depletion and refilling. In agreement with previous studies , we observed an increase in FRET after ER Ca 2+ depletion and a subsequent decrease after ER Ca 2+ refilling. In both control and SARAF overexpressing cells, the rate of FRET increase during ER Ca 2+ depletion and decrease after refilling were similar. With or without SARAF after ER refilling, the time constants of FRET decrease were 11.9*10 À3 ± 0.6*10 À3% /s and 12.9*10 À3 ± 0.7*10 À3% /s, respectively. In contrast, the extent to which the FRET signal was decreased was different, possibly reflecting a reduced amount of STIM1 oligomers in the presence of SARAF ( Figure 7A ). Because the extent of ER Ca 2+ refilling mirrors the oligomeric state of STIM1 (Shen et al., 2011) , these results are in apparent contradiction with reduced I CRAC monitored in SARAF-expressing cells. To test this theoretical discrepancy, we determined the levels of ER Ca 2+ levels under the same experimental conditions as in Figure 7A . Results from this analysis indicated that in agreement with reduced I CRAC and prior to the onset of the STIM1 deoligomerization process, [
] ER was stabilized at lower levels in cells overexpressing SARAF compared to the levels in control cells ( Figure 7B ). In conclusion, these results indicate that SARAF reduces active STIM1 oligomers upon Ca 2+ entry and store refilling even at lower [Ca 2+ ] ER ( Figures 7C and 7D ).
DISCUSSION
By screening for genes that shape mitochondrial Ca 2+ levels, we serendipitously identified SARAF as a regulator of store operated calcium influx. Increasing or decreasing SARAF expression levels resulted in opposite effects on global levels of intracellular Ca 2+ at resting and activated states, indicating an important role for this gene product in the regulation of cellular Ca 2+ homeostasis. SARAF shares similar topology and overall structurefunction relationships with STIM proteins and consists of a single pass ER membrane protein with a cytosolic facing segment responsible for activity, whereas its luminal facing segment engages in regulatory function. Moreover, like STIM1, SARAF also contains a serine-proline rich domain followed by a cluster of basic residues at its C-terminal tail that may aid its interaction with the plasma membrane phospholipids (Huang et al., 2006; Korzeniowski et al., 2009; Park et al., 2009 ) ( Figure 1A ). Whether this similarity bears functional significance is currently unclear; however, our results strongly suggest that STIM is the major target for SARAF regulation. This conclusion is supported by several lines of evidence, as both proteins colocalize to the same organelle where they reside within a short distance from each other (5-10 nm) and undergo dynamic physical interaction in response to Ca 2+ store depletion. The results presented in this work, however, do not rule out additional functional interaction between SARAF and Orai1, and further studies are needed to address this point. SARAF is expressed in the ER membrane and regulates cellular Ca 2+ influx mediated by STIM1 activation of Orai1. SARAF regulation over SOCE, however, is largely dependent on Ca 2+ entry.
The robust ability and the nature by which SARAF regulates I CRAC currents is in favor of the idea that SARAF may be part of the molecular entity responsible for one form of slow Ca
2+
-dependent inactivation process that was previously identified in cultured cells and native tissues (Louzao et al., 1996; Parekh, 1998; Zweifach and Lewis, 1995) . Previous studies that analyzed slow Ca 2+ -dependent inactivation of I CRAC yielded somewhat different findings. In rat basophilic leukemia (RBL) cells inactivation onset depended on cytosolic Ca 2+ , but no appreciable involvement of store refilling was observed. In Jurkat cells, however, a strong dependence on cytosloic Ca 2+ for CRAC channel inactivation was also reported, but about 50% of inactivation was traced to the refilling of stores. Similar to the findings in both studies mentioned above, we find that the onset of CRAC channel inactivation mediated by SARAF critically depends on cytoslic Ca 2+ . Involvement of store refilling, however, is only apparent with the full-length SARAF but not with its short splice isoform. Moreover, we find that the depletion of SARAF expression in Jurkat T cells also diminishes I CRAC inactivation ( Figure 2H ). It is therefore conceivable that differential cell-specific alternative splicing of SARAF may explain some of the discrepancies observed in previous studies and thus may also underlie a mechanism for regulating cell Ca 2+ homeostasis at the posttranscriptional level.
The precise molecular mechanism that underlies the ability of SARAF to sense cytosolic Ca 2+ elevations and induce I CRAC inactivation is unclear at this stage. Recently, via a proteomics approach, a modulator for SOCE activity, an EF-hand containing a cytosolic protein termed CRACR2A, was identified (Srikanth et al., 2010) . CRACR2A binds both Orai1 and STIM1 to aid the stabilization of the active CRAC complexes, mainly under conditions of low abundance of STIM1 and Orai1. Upon the elevation of cytosolic Ca 2+ , CRACR2A is believed to dissociate from the complex to promote the destabilization of the SOCE complex. Like SARAF it also responds to local elevation of Ca 2+ near the plasma membrane. It remains to be seen if CRACR2A has a corresponding effect on I CRAC . Whether the two proteins are part of the same protein complex that regulates CRAC channels is an appealing possibility that awaits future studies. The ER luminal facing segment of SARAF regulates the inhibitory action mediated by the cytosolic facing segment, which has the capability to interact with the C-terminal cytosolic domain of STIM1. The apparent action of SARAF in facilitating ER Ca 2+ refilling-dependent inactivation is, however, likely a consequence of its ability to indirectly respond to changes in [Ca 2+ ] ER and promote an efficient disaggregation of STIM molecules (Figure 7) . The regulatory role of the SARAF ER luminal facing domain is underlined by the enhanced ability of the short isoform of SARAF to inhibit I CRAC independently of store refilling. The fact that a mutation in this region has a dominant negative effect on SOCE activity also suggests that SARAF may be functional as a dimer or in a higher-order complex. The ER luminal facing segment of SARAF, however, does not show clear similarity with any known Ca 2+ binding motifs. In addition, I CRAC measurements in the absence or presence of store refilling yield similar $2-fold differences in both control and SARAF-expressing cells (Figures 2A and S2C) , and translocation of SARAF to ER-PM regions depends on that of STIM1 but not on store depletion per se (Figure 3 ). It is therefore less likely that SARAF directly binds Ca 2+ ions and thus raises the possibility that SARAF may respond to changes in [Ca 2+ ] ER indirectly through interaction with STIM or other ER Ca 2+ -sensitive proteins or is regulated by other physiological mechanisms (Enyedi et al., 2010; Hawkins et al., 2010) . The functional interaction of SARAF with STIM1 may point toward the former possibility, were coupling between STIM1 Ca 2+ occupancy and the SARAF inhibitory mode, found to occur. Such a scenario is in agreement with spontaneous activation of STIM1 proteins without ER Ca 2+ depletion, observed after knockdown of SARAF expression or with a more efficient disaggregation and stabilization of inactive STIM1 proteins at lower ER Ca 2+ levels, after an increase in SARAF expression.
The direct mode by which SARAF affects SOCE inactivation after ER Ca 2+ refilling is currently unresolved and awaits future studies.
Although no direct evidence provided to date shows that mutations in SARAF are linked to any disease state in humans, studies employing various differential expression or transcriptome-profiling strategies have recently identified SARAF as a biomarker linked to prostate cancer (Romanuik et al., 2009a ), Alzheimer's disease (Twine et al., 2011) , and dilated cardiomyopathy (DCM) (Camargo and Azuaje, 2008) . Notably, most of these disease states are accompanied by abnormal intracellular Ca 2+ handling. It is also interesting to note that both STIM1 and SARAF transcripts have been shown to be positively modulated by androgens, implying common regulatory mechanisms of these genes expression levels (Berry et al., 2011; Romanuik et al., 2009b) . In summary we have identified the gene product of TMEM66, SARAF, as a regulator of store operated calcium entry. SARAF promotes slow I CRAC inactivation after Ca 2+ entry and refilling of the endoplasmic reticulum. This physiological role places SARAF as a dominant player in a protective mechanism designed to prevent rapid overfilling of cells with Ca 2+ ions.
EXPERIMENTAL PROCEDURES Fluorescent Measurements of Intracellular Ions
Typically, 6-8 hr after plasmid transfection and 17-24 hr before starting the experiments, cells were plated onto 24 mm cover glass coated with L-polylysine. On the day of the experiments, the cover glass was mounted on an imaging chamber and washed with Ringer solution. Fura-2 loading of cells was performed as previously described (Palty et al., 2010) . Cytosolic Ca All experiments were conducted with Ringer's solutions containing 130 mM NaCl, 20 mM HEPES,15 mM Glucose, 5 mM KCl, and 0.8 mM MgCl 2 with the pH adjusted to 7.4. Ringer's solution was supplemented with 2 mM CaCl 2 or 1 mM EGTA (Ca 2+ free) as indicated. For all single cell imaging experiments, traces of averaged responses, recorded from 10 to 50 cells in each experiment, were plotted with KaleidaGraph. All experiments were repeated 2 to 8 times. Statistical significance was determined with t test analysis; p < 0.05 was considered significant. All data are shown as average ± SEM.
NFAT Translocation Assay
Monitoring of nuclear translocation of NFAT-GFP was performed 30-48 hr posttransfection in HEK293-T or HeLa cells. At the start of each experiment, cells were washed twice with Ca 2+ -free Ringer's solution, and 2 mM BHQ or 0.2 mM Tg were added for 5 min. Cells were then washed with Ca 2+ -free Ringer's solution for additional 5 min and incubated for 30 min in a 2 mM Ca 2+ -containing Ringer's solution. Localization of NFAT-GFP in cells was examined by fluorescent microscopy before and after SOCE induction.
Electrophysiological Recordings
Recorded HEK293-T or HEK293 cells were transfected 24-36 hr prior to electrophysiology experiments. Each transfection contained STIM1 and Orai1 with or without SARAF (1 mg each). Cells were transferred to the measurement chamber more than 6 hr before measurements for HEK293 cells and 10-20 min for Jurkat cells. Membrane currents were recorded under voltage-clamp conditions with whole-cell variation of the patch-clamp configuration by using Axopatch 200B (Axon Instruments). Patch pipettes were fabricated from borosilicate glass capillaries (2-5 MU). Signals were analog filtered with a 1 kHz low-pass Bessel filter. Data acquisition and analysis were done with pCLAMP 9 software (Axon Instruments). All data were leakcorrected with the current elicited in Ca 2+ -free Ringer's solution at the beginning of each experiment. More detailed information and solutions used are in Extended Experimental Procedures.
ACCESSION NUMBERS
The GeneBank accession number for SARAF is JQ348891, and for SARAF short isoform it is JQ348892.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six figures, and one movie and can be found with this article online at doi:10.1016/j.cell.2012.01.055.
